bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Recommendation of “Hold” by Brokerages
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have earned an average recommendation of “Hold” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating on the […]
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have earned an average recommendation of “Hold” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating on the […]
